Moderna Says FDA Agrees to Consider Revised mRNA Influenza Vaccine...

shared a link

2026-02-18 16:00:08

Moderna Says FDA Agrees to Consider Revised mRNA Influenza Vaccine Application

The Moderna campus in Norwood, Mass., on Dec. 2, 2020. Joseph Prezioso/AFP via Getty ImagesModerna on Feb. 18 said the Food and Drug Administration has agreed to review a revised application from the

0 Comments 0 Shares 27 Views